1 From the Cardiovascular Laboratory, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Electrocardiographic analysis of the P waves occurring in a series of 113 normal subjects and 100 patients with specifically defined valvular lesions are reviewed. The former methods of analysis showed a marked lack of specificity. By dividing the P wave in lead V1 into initial and terminal portions, a measure designated as the P terminal force has been derived. This measure is of value in two respects: (1) it correctly separates normal subjects from those patients with left-sided valvular lesions in 92 per cent of this series and (2) once a given valve lesion is suspected clinically, this measure enables one to make an estimation of the severity of that lesion from the degree of abnormality of the P terminal force at V1. The P terminal force does not indicate the type of valvular disease present, nor does it correlate with any one specific hemodynamic measure. The abnormality does appear to be related, within each separate type of valve disease, to the specific hemodynamic abnormality of that type of valvular involvement. The anatomic and electrophysiologic changes that might relate to these P-wave changes are discussed.
© 1964 American Heart Association, Inc.
P-Wave Analysis in Valvular Heart Disease
This article has been cited by other articles:
 |
|
 |
|
  B. B. Altunkeser, K. Ozdemir, H. Gok, A. Temizhan, M. Tokac, and T. Karabag Can P Wave Parameters Obtained from 12-Lead Surface Electrocardiogram be a Predictor for Atrial Fibrillation in Patients Who Have Structural Heart Disease? Angiology, July 1, 2003; 54(4): 475 - 479. [Abstract] [PDF]
|
|
|
|
|
|
B. B. Altunkeser, K. Ozdemir, H. Gok, M. Yazici, and A. Icli The Effect of Valsalva Maneuver on P Wave in 12-Lead Surface Electrocardiography in Patients with Paroxysmal Atrial Fibrillation Angiology, July 1, 2002; 53(4): 443 - 449. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Gerdts, L. Oikarinen, V. Palmieri, J. E. Otterstad, K. Wachtell, K. Boman, B. Dahlof, and R. B. Devereux Correlates of Left Atrial Size in Hypertensive Patients With Left Ventricular Hypertrophy: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study Hypertension, March 1, 2002; 39(3): 739 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J D Somauroo, J R Pyatt, M Jackson, R A Perry, and D R Ramsdale An echocardiographic assessment of cardiac morphology and common ECG findings in teenage professional soccer players: reference ranges for use in screening Heart, June 1, 2001; 85(6): 649 - 654. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Corrado, C. Basso, M. Schiavon, and G. Thiene Screening for Hypertrophic Cardiomyopathy in Young Athletes N. Engl. J. Med., August 6, 1998; 339(6): 364 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Charron, O. Dubourg, M. Desnos, M. Bennaceur, L. Carrier, A.-C. Camproux, R. Isnard, A. Hagege, J. M. Langlard, G. Bonne, et al. Clinical Features and Prognostic Implications of Familial Hypertrophic Cardiomyopathy Related to the Cardiac Myosin-Binding Protein C Gene Circulation, June 9, 1998; 97(22): 2230 - 2236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Charron, O. Dubourg, M. Desnos, R. Isnard, A. Hagege, A. Millaire, L. Carrier, G. Bonne, F. Tesson, P. Richard, et al. Diagnostic Value of Electrocardiography and Echocardiography for Familial Hypertrophic Cardiomyopathy in a Genotyped Adult Population Circulation, July 1, 1997; 96(1): 214 - 219. [Abstract] [Full Text]
|
|
|
|
|
|
K. Ishikawa and A. Yanagisawa Influence of an Upward Shift in the V1 Electrode Position on the P-Terminal Force Angiology, July 1, 1981; 32(7): 485 - 488. [Abstract] [PDF]
|
|
|
|
|
|
E. Sivertssen The Atrial Complex in Right Atrial Electrocardiography (Ra Ecg) Angiology, January 1, 1973; 24(1): 3 - 16. [PDF]
|
|
|
|
|
|
J. L. Saunders, K. J. Schulz, V. Maranhao, H. Goldberg, and J. B. Calatayud P Wave Changes After Open Heart Mitral Commissurotomy for Isolated Mitral Stenosis Angiology, April 1, 1968; 19(4): 238 - 246. [PDF]
|
|